Novel 1,3-dipropyl-8-(1-heteroarylmethyl-1H-pyrazol-4-yl)-xanthine derivatives as high affinity and selective A2B adenosine receptor antagonists
- 1 January 2006
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 16 (2) , 302-306
- https://doi.org/10.1016/j.bmcl.2005.10.002
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- The discovery of a selective, high affinity A2B adenosine receptor antagonist for the potential treatment of asthmaBioorganic & Medicinal Chemistry Letters, 2005
- CVT-4325: a potent fatty acid oxidation inhibitor with favorable oral bioavailabilityBioorganic & Medicinal Chemistry Letters, 2004
- Design, Synthesis, and Biological Evaluation of New 8-Heterocyclic Xanthine Derivatives as Highly Potent and Selective Human A2BAdenosine Receptor AntagonistsJournal of Medicinal Chemistry, 2004
- Medicinal Chemistry and Pharmacology of A2B Adenosine ReceptorsCurrent Topics in Medicinal Chemistry, 2003
- Induction of interleukin 8 release from the HMC-1 mast cell line: Synergy between stem cell factor and activators of the adenosine A2b receptorBiochemical Pharmacology, 2002
- Inhibition of human mast cell activation with the novel selective adenosine A2B receptor antagonist 3-isobutyl-8-pyrrolidinoxanthine (IPDX)Biochemical Pharmacology, 2001
- Bioisosterism: A Rational Approach in Drug DesignChemical Reviews, 1996
- Adenosine A2b receptors evoke interleukin-8 secretion in human mast cells. An enprofylline-sensitive mechanism with implications for asthma.Journal of Clinical Investigation, 1995
- 1,3-Dialkyl-8-(p-sulfophenyl)xanthines: potent water-soluble antagonists for A1- and A2-adenosine receptorsJournal of Medicinal Chemistry, 1985
- Adenosine inhibits and potentiates IgE-dependent histamine release from human lung mast cells by an A2-purinoceptor mediated mechanismBiochemical Pharmacology, 1984